This Review outlines the occurrence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NASH) in patients who have undergone liver transplantation for prior NASH-related cirrhosis (recurrent) or other liver indications (de novo).
- Amedeo Lonardo
- Alessandro Mantovani
- Giovanni Targher